Capital International Inc’s Integra LifeSciences IART Stock Holding History

Capital International Inc’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-81,630	Closed	-$4.76M	–	267
2019 Q4	$4.76M	Sell	81,630 -54,779	-40%	-$3.26M	0.07%	138
2019 Q3	$8.19M	Buy	136,409 +94,629	+226%	+$5.64M	0.12%	121
2019 Q2	$2.33M	Sell	41,780 -1,170	-3%	-$60.3K	0.16%	118
2019 Q1	$2.39M	Buy	42,950 +5,600	+15%	+$285K	0.28%	80
2018 Q4	$1.68M	Buy	37,350 +3,050	+9%	+$167K	0.23%	87
2018 Q3	$2.26M	Buy	34,300 +16,700	+95%	+$1.04M	0.29%	77
2018 Q2	$1.13M	Buy	17,600 +8,200	+87%	+$508K	0.17%	96
2018 Q1	$520K	Buy	+9,400	New	+$493K	0.08%	136

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Capital International Inc's IART Position: Q1 2020 in Review

Capital International Inc sold out of Integra LifeSciences (IART) in Q1 2020, closing a stake of 81,630 shares — an estimated $4.76M sold.

Capital International Inc first reported a position in IART in Q1 2018 and held it in 8 quarters. The position peaked at $8.19M in Q3 2019. 258 funds tracked by Wall St. Rank hold IART as of Q1 2020.

Capital International Inc reported no remaining Integra LifeSciences position as of Q1 2020 after selling out during the quarter.
Capital International Inc sold 81,630 Integra LifeSciences shares in Q1 2020, an estimated $4.76M.
Capital International Inc first reported a position in Integra LifeSciences in Q1 2018 and held it in 8 quarters.
Capital International Inc's Integra LifeSciences position peaked at $8.19M in Q3 2019.
258 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2020.

Based on Capital International Inc's 13F filing for Q1 2020, filed 15 May 2020.